Dorothy Abel

489 total citations
15 papers, 358 citations indexed

About

Dorothy Abel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dorothy Abel has authored 15 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dorothy Abel's work include Aortic aneurysm repair treatments (12 papers), Vascular Procedures and Complications (6 papers) and Infectious Aortic and Vascular Conditions (5 papers). Dorothy Abel is often cited by papers focused on Aortic aneurysm repair treatments (12 papers), Vascular Procedures and Complications (6 papers) and Infectious Aortic and Vascular Conditions (5 papers). Dorothy Abel collaborates with scholars based in United States, Thailand and Switzerland. Dorothy Abel's co-authors include Mark F. Fillinger, Tina Morrison, Matthew P. Sweet, Rodney A. White, William M. Abbott, Thomas J. Fogarty, Paul Didisheim, Adam W. Beck, Jerry Goldstone and D. Craig Miller and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Vascular Surgery and Journal of Vascular and Interventional Radiology.

In The Last Decade

Dorothy Abel

15 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothy Abel United States 9 329 212 115 19 11 15 358
Sho Nakao Japan 7 124 0.4× 209 1.0× 71 0.6× 17 0.9× 39 3.5× 34 271
Elie Girsowicz Canada 10 204 0.6× 94 0.4× 179 1.6× 7 0.4× 7 0.6× 36 282
G.J. Akkersdijk Netherlands 9 330 1.0× 268 1.3× 112 1.0× 6 0.3× 4 0.4× 10 385
Matthew Joe Grima United Kingdom 10 229 0.7× 135 0.6× 107 0.9× 7 0.4× 7 0.6× 24 259
Salim Dabbah Israel 6 136 0.4× 328 1.5× 83 0.7× 16 0.8× 24 2.2× 8 358
Peppino Pugliese Italy 10 221 0.7× 320 1.5× 169 1.5× 14 0.7× 11 1.0× 30 370
Jan-Willem Hinnen Netherlands 11 268 0.8× 120 0.6× 95 0.8× 33 1.7× 14 1.3× 24 317
Alan T. Saunders United States 8 356 1.1× 171 0.8× 189 1.6× 8 0.4× 5 0.5× 11 401
Alexander Christian United States 2 126 0.4× 324 1.5× 67 0.6× 8 0.4× 58 5.3× 4 344
Tsung Po Tsai United States 5 91 0.3× 301 1.4× 131 1.1× 10 0.5× 23 2.1× 7 315

Countries citing papers authored by Dorothy Abel

Since Specialization
Citations

This map shows the geographic impact of Dorothy Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy Abel more than expected).

Fields of papers citing papers by Dorothy Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothy Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy Abel. The network helps show where Dorothy Abel may publish in the future.

Co-authorship network of co-authors of Dorothy Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothy Abel. A scholar is included among the top collaborators of Dorothy Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothy Abel. Dorothy Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Grace J., Richard P. Cambria, Joseph V. Lombardi, et al.. (2019). Thirty-day outcomes from the Society for Vascular Surgery Vascular Quality Initiative thoracic endovascular aortic repair for type B dissection project. Journal of Vascular Surgery. 69(3). 680–691. 34 indexed citations
2.
Beck, Adam W., Joseph V. Lombardi, Dorothy Abel, et al.. (2017). Innovative postmarket device evaluation using a quality registry to monitor thoracic endovascular aortic repair in the treatment of aortic dissection. Journal of Vascular Surgery. 65(5). 1280–1286. 19 indexed citations
3.
Holmes, David R., Robert M. Califf, Andrew Farb, et al.. (2016). Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United States. Journal of the American College of Cardiology. 68(17). 1908–1915. 13 indexed citations
4.
Abel, Dorothy & Andrew Farb. (2013). Application of Investigational Device Exemptions regulations to endograft modification. Journal of Vascular Surgery. 57(3). 823–825. 9 indexed citations
5.
Morrison, Tina, et al.. (2012). PS6. Population-based Study of Age and Gender Effects in Aneurysm Anatomy. Journal of Vascular Surgery. 55(6). 30S–30S. 3 indexed citations
6.
Abel, Dorothy & Jose P. Morales. (2011). Food and Drug Administration commentary on the SVS masterfile for acute complicated type B aortic dissections and transections. Journal of Vascular Surgery. 53(4). 1079–1081. 3 indexed citations
7.
Sweet, Matthew P., Mark F. Fillinger, Tina Morrison, & Dorothy Abel. (2011). The influence of gender and aortic aneurysm size on eligibility for endovascular abdominal aortic aneurysm repair. Journal of Vascular Surgery. 54(4). 931–937. 140 indexed citations
8.
Sweet, Matthew P., Tina Morrison, Dorothy Abel, & Mark F. Fillinger. (2010). The Influence of Gender on Eligibility for Endovascular Aneurysm Repair. Journal of Vascular Surgery. 52(4). 1115–1115. 1 indexed citations
9.
Abel, Dorothy, et al.. (2006). Evolution and Future of Preclinical Testing for Endovascular Grafts. Journal of Endovascular Therapy. 13(5). 649–659. 18 indexed citations
10.
Veith, Frank J., William M. Abbott, James S.T. Yao, et al.. (2003). Guidelines for Development and Use of Transluminally Placed Endovascular Prosthetic Grafts in the Arterial System. Journal of Vascular and Interventional Radiology. 14(9). S405–S417. 12 indexed citations
11.
Abel, Dorothy. (2003). Ongoing FDA evaluation of approved endovascular grafts. Journal of Vascular Surgery. 37(4). 902–903. 1 indexed citations
12.
Abel, Dorothy, et al.. (2002). Preclinical testing for aortic endovascular grafts: Results of a Food and Drug Administration workshop. Journal of Vascular Surgery. 35(5). 1022–1028. 12 indexed citations
13.
Pritchard, William F., Dorothy Abel, & John W. Karanian. (1999). The US Food and Drug Administration Investigational Device Exemptions and Clinical Investigation of Cardiovascular Devices: Information for the Investigator. Journal of Vascular and Interventional Radiology. 10(2). 115–122. 1 indexed citations
14.
Pritchard, William F., Dorothy Abel, & John W. Karanian. (1999). The US Food and Drug Administration investigational device exemptions (IDE) and clinical investigation of cardiovascular devices: Information for the investigator. Journal of Vascular Surgery. 29(3). 566–574. 3 indexed citations
15.
Veith, Frank J., William M. Abbott, James S.T. Yao, et al.. (1995). Guidelines for development and use of transluminally placed endovascular prosthetic grafts in the arterial system. Journal of Vascular Surgery. 21(4). 670–685. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026